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DISTRIBUTION AND KINETICS OF 14C-VECURONIUM IN
RATS AND MICE
P. G. WASER, H. WIEDERKEHR, A. CHANG SIN-REN AND
E. KAISER-SCHONENBERGER
Vecuronium-bromide is the monoquaternary
analogue of pancuronium (Savage, Sleigh and
Carlyle, 1980). Thus one might anticipate little
change in activity because of this structural
similarity or, alternatively, there could be a
substantial decrease in neuromuscular blocking
activity as with other monoquaternary com-
pounds. Since the anaesthetist tends to use
short-acting non-depolarizing neuromuscular
blockers, vecuronium will be used extensively.
As a result, its distribution to the organs, and
its pathways of elimination, are of clinical
importance.
MATERIALS AND METHODS
Animal preparation, drug application and
sectioning
Twenty male rats were anaesthetized by the i.p.
injection of 20% urethane solution (1.8mg/g
animal weight), a tracheostomy undertaken and
artificial ventilation instituted via a tracheal tube.
The ECG was monitored throughout. 14C-
Vecuronium bromide 6.76 |ig g"1 (specific ac-
tivity 2.39 mCi mmol litre"1 = 3.7 nCi mg~l) or
0.025 nCi/g animal weight, synthesized in our
isotope laboratory by a special selective methy-
lation technique (fig. 1), was injected via the tail
vein. This dose is equal to seven times the LD100.
During the period of complete muscle paralysis
artificial ventilation (48 b.p.m.: 95 % oxygen: 5 %
carbon dioxide 4 ml) was maintained (Harvard
rodent ventilator). At time intervals of 2, 5,20, 60
and 120 min after injection, four animals from
each of the five groups were killed by immediate
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SUMMARY
The distribution and kinetics of 1AC-vecuronium
were studied in rats and mice. llC-Vecuronium
accumulated rapidly in the liver. Both unchanged
and metabolized vecuronium were excreted with
the bile into the intestines and stomach. Re-
absorption in the gut was probably responsible
for an enterohepatic increase in radioactivity in
the liver after one hour. Excretion through the
kidneys increased continuously from low values
after the initial peak. Binding in compartments
with acidmucopo/ysaccharides such as cartilage,
connective tissue etc., was less important. Blood-
brain barrier and placenta were permeable only to
a small degree.
immersion in a mixture of hexane/solid carbon
dioxide (temperature — 70 °C). The frozen ani-
mals were embedded in a gel of carboxymethyl
cellulose (water-Na-CmC) and submerged in the
cooling mixture and frozen to a solid block over
20 min. At six different levels, sagittal sections
were cut (Cryo-microtome Type PMV-450,
LKB, Stockholm) from the block, which was
covered by broad scotch tape (3M). The under-
cutting produced tape-mounted sections of 20 |im
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FIG. 1. Chemical structure of vecuronium. *Carbon-14
label.
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thickness. These were first dried for 3 days in the
deep freeze, and autoradiographs were obtained.
Corresponding sections were kept for histological
staining and localization of radioactive tracers.
The rest of the animal was stored in plastic bags
in the deep freeze for radioactivity analysis by
liquid-scintillation counting.
Whole-body autoradiography (WBAR)
The 20-|im mounted sections were covered by
x-ray films (NS-25-No-Screen films, Eastman
Kodak), and exposed for 16 weeks at — 20 °C
in the dark. The films were developed under
standardized conditions. The densitometric eval-
uation of the degree of film blackening was
achieved with a densitometer (TD-504 by Mac-
beth Kollmorgen). The evaluation of the degree of
blackening of the films utilized a calibration scale
which was obtained by simultaneous exposure of
14C-glucose impregnated emulsion sheets on the
films (Cross, Groves and Hesselbo, 1974). An
exponential function for correcting the saturation
of total film blackening was applied (Keller and
Waser, 1982).
Liquid scintillation counting (LSC)
Samples of tissues or body fluids (20-200 mg)
were taken out of the frozen animals, weighed and
mixed with Soluene-100 1 ml (Packard) in vials,
shaken on a 50 °C waterbath until completely
dissolved after 3-5 h. Isopropanol 0.5 ml and
30% HjO, 0.5 ml were added and, after the exo-
thermic reaction, mixed with Insta-Gel (Packard)
and hydrochloric acid 0.5 mol litre"1 in a ratio of
9:1. These tissues were measured in a counter
(Tricarb 3375, Packard). The correlation between
ratio (R) and efficiency (E) was determined
experimentally by determination of a quenching
curve. As radioactive standard, I4C-hexane (Amer-
sham International Ltd) with a specific activity of
1.123 x 108 d min"1 g"1 was used.
Comparison between the results of densito-
metric determination (D) and liquid scintillation
counting (L) of radioactivity was expressed as the
ratio between the two relative standard deviations:
en o/
Experiments with mice
Twelve male mice of average weight (24-27 g)
were anaesthetized by i.p. injection of 20%
urethane solution. I4C-Vecuronium bromide
0.02-0.2 uCi g"1 was administered via a tail vein.
The animals' lungs were ventilated artificially
(95 % oxygen, 5 % carbon dioxide) via a tracheal
cannula. The ECG was monitored and body
temperature maintained at 36-37 °C. The animals
were killed 2, 7 and 10 min after the i.v. injection,
and immediately frozen. Eight pregnant mice,
weighing 60-70 g, received 14C-vecuronium 0.02
or 0.04 uCi g"1. They were killed 2 or 5 min after
the i.v. injection and frozen. The microtome
sections were processed as described above, and
the exposed films evaluated qualitatively but not
quantitatively, because in this pilot experiment
the doses given were very high, in order to produce
positive autoradiographs.
RESULTS
Whole-body autoradiography (rats)
An immediate accumulation of radioactivity
(after 2-5 min) occurred in the kidneys and liver
(fig. 2). The liver concentration then decreased
rapidly to one-third its orignal value by 20 min.
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FIG. 2. Distribution of "C-vecuronium in rat organs at
different times. Densitometric measurement of whole-body
autoradiographs. Ordinate: radioactivity compared with con-
centrations in blood at 2 min = 100%. The elimination organs
(liver, kidney) have most, the nervous system least radio-
activity; intermediate concentrations of radioactivity in
intervertebral discs and sternum.
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FIG. 3. Autoradiographs of section through liver, kidney, stomach, intestines, vena cava 2 min after i.v.
injection of 14C-vecuronium 0.025 uCi g"1. The liver shows lobular structure with high radioactivity in
the centre (central vein), and in the bile (ductus choledochus) entering the duodenum and stomach. The
mucous membrane of the small intestine has little radioactivity. The kidneys excrete a large amount
through their glomerulae and tubules into the kidney pelvis. Adrenal gland—no radioactivity.
Ag = adrenal gland; Bi = bile; Bl = bladder; Br — brain; F = fetus; Gb = gall bladder; H = heart;
ID = intervertebral disc; In = intestine; K •= kidney; Kc — kidney cortex; Km = kidney medulla;
Kp = kidney pelvis; L = liver; La = larynx; P = lungs; PI = placenta; S •» stomach; Sc = spinal cord;
Sp = spleen; St = sternum; Vc •= vena cava.
The autoradiography of liver tissue had a lobular
aspect (figs 3, 4). The central veins of the lobules
were mostly black for more than 20 min, and the
liver cells remained uniformly dark for 2 h. At the
same time the bile ducts were filled with highly
radioactive bile.
The radioactivity of the renal cortex and
medulla decreased simultaneously. The urine in
the pelvis of the kidneys had a high concentration
of radioactivity during the first 20 min which
decreased slowly over the next 20-60 min.
A second period of increased radioactivity in
the liver and kidneys followed after 20 min (fig. 5).
The amount of 14C-metabolites in the liver
decreased after 60 min. Ample radioactivity was
noted in the intestine. Radioactivity in the renal
cortex, and in the urine in the pelvis of the kidney
increased, over 60-120 min, demonstrating active
excretion in the urine, measured in the kidney
pelvis.
Much less radioactivity was found in the lungs,
spleen, myocardium, skeletal muscle, bones,
salivary and adrenal glands, and thymus, with a
first peak 2 min after injection. The cortex of the
adrenals had more radioactivity than the medulla.
Very little radioactivity was observed in the
central nervous system.
The blood 14C-concentration followed an ex-
ponential decrease with three different phases
(<*) P) y), in the same range as the mentioned
organ activities (fig. 6). The bile—highly radio-
active immediately after the injection—flows via
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FIG. 4. Autoradiography of the same organs as in figure 3, 5 min (left) and 2 h (right) after i.v. injection.
The liver tissue loses its lobular structure after 2 h, and more radioactivity has entered the intestines,
but not the mucosa. The stomach is full of radioactive compounds; the kidneys are unchanged as before;
adrenal gland is free of radioactivity. For key to abbreviations, see figure 3.
the bile duct to the duodenum, the intestines and
the stomach. The radioactivity remained within
the different parts of the intestines during the
experiment and much of it was bound to the
surface of mucous membrane and, perhaps, even
absorbed.
In some tissues as cartilage of the sternum,
intervertebral discs, snout, tendons and connec-
tive tissues, there was an immediate accumulation
of considerable radioactivity—at first similar to
that in the kidneys (fig. 7). However, the
radioactivity decreased rapidly to average values
within 20 min.
Distribution of radioactivity in mice
The distribution of radioactivity in the organs
of mice was different than in rats. As mice are more
sensitive to vecuronium than rats, the injected
dose for autoradiography was relatively high, but
proved useful for testing the permeability of the
blood-brain and placental barriers. Two minutes
after the i.v. injection of vecuronium the blood
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FIG. 5. Liquid scintillation counting of organ probes of the
same rats show a similar distribution: high concentrations of
radioactivity in kidneys and liver over 2 h, little in skeletal
muscle and lung. Mean values ±SEM.
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FIG. 6. The radioactivity (±SEM) of vecuronium and
metabolites in the excretion fluids is much greater than in the
blood. The concentration in the bile is nearly 1000-fold; in the
urine, as measured in the kidney pelvis, 10-fold.
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FIG. 7. As with other quaternary neuromuscular blockerj,
accumulation of positively charged drug molecules is detec-
table in the cartilage of bones in the vertebral discs, sternum,
etc. It is less marked with vecuronium than with pancuronium.
Vertical bars represent SEM.
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FIG. 8. Whole-body autoradiography of I4C-vecuronium in a mouse, 10 min after i.v. injection of
0.025 uCi g~'. The distribution in the organs is similar to that in the rat. Much radioactivity is already
concentrated in the intervertebral discs, the sternum, the trachea and larynx. For key to abbreviations,
see figure 3.
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FIG. 9. Distribution in pregnant mouse 5 min after i.v. injection of 0.04 (iCi g~'. Even with a high dose,
radioactivity is not detectable in the fetus, but is present in the placenta, with similar densities in the
kidney, a renal vein and the intestinal mucosa. Intense radioactivity in the spinal column, sternum and
larynx. For key to abbreviations, see figure 3.
was more radioactive than the liver tissue of male
and pregnant animals. However, as radioactivity
accumulated in the liver, both tissues had similar
concentrations after 10 min. The bile contained
little radioactivity and the gall bladder remained
free of radioactivity. In contrast, the kidneys and
the urine in the pelvis and in the bladder were
darker than the liver, and the gastrointestinal tract
contained (after 10 min) traces of radioactive
material—mainly in the mucous membrane and
partly in its lumen. There was no radioactivity in
nervous tissues: only some of the blood vessels in
the brain were blackened. The cartilage of joints,
intervetebral discs, larynx and connective tissue
became increasingly black within 10 min (fig. 8).
The placentae of pregnant animals were radio-
active, similar to the intestines, but there were
only slight traces of radioactivity in the fetuses
(similar to the brain) (fig. 9). Even the livers
of the embryos did not produce positive auto-
radiographs.
Liquid scintillation analysis of rat organs and
mouse fetuses
The activities of a few typical uniform tissues
and organs, measured by this method during the
time course of the study, correspond largely with
the densitometric measurements of the auto-
radiographs. However, no details of distribution
in discrete small areas are recognizable. The
comparison of the relative (%) values shows the
close coincidence of the measurements by the two
analytical methods.
Thirty minutes after i.v. injection (0.49 nCi/g
animal weight) of 14C-vecuronium to pregnant
mice, the fetuses contained only 2.1% of the
radioactivity of the injected dose per g tissue
weight.
DISCUSSION
Based on the timing peaks of radioactivity in the
various organs, we calculate that the distribu-
tion of 14C-vecuronium is over 2 min after i.v.
1050 BRITISH JOURNAL OF ANAESTHESIA
injection. Blockade of neuromuscular trans-
mission—with the 7 times LD100 dose (high,
because this radioactivity is required for positive
autoradiographs)—starts immediately but lasts,
on average, only 10 min when one considers
ventilatory movements. Thus onset time and
duration of relaxation are shorter than with
pancuronium (Durant, Houwertjes and Crul,
1980).
Vecuronium is metabolized in the liver and one
metabolite, the 3-deactylated Org 7268, is ex-
creted in bile and urine. We found only traces of
this metabolite in the plasma. Therefore, the
radioactivity in blood and organs, except the liver,
is produced mostly by WC-vecuronium (Waser
and Wiederkehr, in preparation).
Much radioactivity is extracted within the first
2 min by the liver and excreted through the bile
into the intestines. The radioactivity in the
stomach is probably the result of reflux from the
duodenum. The radioactivity accumulated in
the liver is 5 times greater than the blood con-
centration. Pancuronium, with an activity in the
liver only 2 times greater than that in plasma after
60 min (Waser, 1973), is markedly different in
its distribution, probably because of the more
lipophilic character of vecuronium and its rapid
metabolism in the liver cells. The second peak of
radioactivity in the liver (between 20 and 60 min)
may be attributable to reabsorption of 14C-
vecuronium excreted with the bile into the
intestine, whereas the more hydrophilic metabo-
lite will be excreted through the kidneys.
Lower concentrations of radioactivity were
found in the kidneys at the start of distribution.
After 5 min they were similar to those in the liver.
The urine in the renal pelvis and in the bladder
was strongly radioactive at the beginning of the
excretion phase, then diminished and increased
again after 60 min. This second wave of excretion
followed the second liver peak. The total elimi-
nation through the kidney was not prominent at
the start, but became important after 60 min.
There was an immediate uptake of vecuronium
into different tissues containing acid mucopoly-
saccharides, such as cartilage, connective tissue,
tendons. The uptake occurred immediately after
the first pass of 14C-vecuronium through the local
circulation of these tissues (nucleus pulposus).
Then the accumulation decreased rapidly—within
the first 5 min—and then slowly in two stages over
the next 60 min. The difference between the
movement of other short-acting neuromus-
cular blockers (pancuronium (Waser, 1973),
alcuronium (Waser and Luthi, 1966)) into this
storage compartment and that of vecuronium is
evident, since with vecuronium it occurs early and
is of short duration. The liberation of non-
metabolized drug from these compartments into
the blood stream will not prolong the neuro-
muscular blockade as this second inflow to the
blood will be taken up immediately by the liver,
where it will be partly metabolized and excreted
through the bile.
The three kinetic phases of the radioactivity in
plasma (fig. 10) can be explained as follows:
a-phase—after the distribution by uptake into the
liver and other organs or compartments as well as
elimination through the kidney; p-phase—re-
appearance from the skeletal muscles and the
mucopolysaccharide binding sites, again uptake
into liver and metabolism producing more polar
water-soluble metabolites; y-phase—by the rest
of vecuronium returning from the organs and
water soluble metabolites being excreted now
mainly through the kidneys.
During the early phases the extraction by the
liver and the elimination of vecuronium and its
metabolites with the bile are the most important
of its kinetics. It is much greater than excretion
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FIG. 10. The radioactivity ( ± S D ) in the blood of "C-
vecuronium and metabolites) measured with whole-body
autoradiography and liquid scintillation counting diminishes
in three phase (a, p, y) in nearly identical manner.
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through the kidneys and in the urine. With
pancuronium, a bisquaternary highly polar com-
pound, this proportion is reversed and in favour
of elimination through the kidneys (Upton et al.,
1982). The shifting of 14C-vecuronium to the
mucopolysaccharide-containing compartments
(cartilage, connective tissue) is less important than
with pancuronium. The relatively short duration
of muscle relaxation produced by vecuronium is
mostly the result of its rapid elimination, plasma
binding (60-80%) and high extraction into the
liver.
The pilot experiments in mice demonstrated
some differences in the distribution of radio-
activity compared with the rats. Some minutes
after the injection of 14C-vecuronium, the clear-
ance of blood from the liver was smaller, and the
kidneys and the urine contained more radio-
activity. This may be because of the high injected
doses. After 10 min this relation was partly
reversed, and in the pregnant animals became at
least equal. The intestines contained large
amounts of radioactive bile, but the urine con-
tinued to be the main pathway of elimination.
Possibly, in pregnancy, the elimination pathway
through the liver-bile system is used less than in
normal animals. There is a difference between
rats and mice, as there was little radioactivity
in the bile ducts of the latter, and the gall bladders
were free of radioactivity.
Finally, the central nervous system with plenty
of lipids in its membranes and neurones, contained
very little 14C-vecuronium. The passage through
the blood-brain barrier, as through the placental
barrier, is very limited; indeed, it is virtually zero
(Demetriou et al., 1982).
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